Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck U.S. Human Health

Executive Summary

Realigned operations divided into "customer business units" -- with responsibility for physicians, HMOs, hospitals, group purchasing organizations "and other important customer segments" - - and "region business units" -- with responsibility for six geographic markets, Merck says. Unit President Richard Lane heads the management team that includes Exec VP-Customer Business Units Simon Benito, Senior VP-Region Business Units Martin Carroll and Senior VP-Product Planning & Business Strategy Robert Glaser. Louis Sherwood continues as senior VP-medical & scientific affairs. The reorganization was described by Lane as an effort to make Merck "a more customer-focused operation" ("The Pink Sheet" Nov. 1, T&G-12).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS023565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel